Silence Therapeutics (SLN) Exchange Rate Effect (2024 - 2026)
Silence Therapeutics (SLN) posted Exchange Rate Effect of -$17000.0 for Q1 2026, up 86.82% sequentially from -$129000.0 in Q4 2025, and down 107.33% YoY from $232000.0 in Q1 2025.
Silence Therapeutics (SLN) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Silence Therapeutics has reported Exchange Rate Effect for 3 years, with the latest figure at -$17000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 107.33% year-over-year to -$17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$54000.0 (down 116.51% YoY) and the FY2025 annual result came in at $195000.0, up 225.0% from the prior year.
- Exchange Rate Effect rose to -$17000.0 in Q1 2026 per SLN's latest filing, from -$129000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $268000.0 in Q3 2024 and troughed at -$159000.0 in Q4 2024.
- A 3-year average of $26444.4 and a median of -$17000.0 in 2026 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 1514.29% in 2025, down 139.55% in 2025.
- Over 3 years, Exchange Rate Effect stood at -$159000.0 in 2024, then rose by 18.87% to -$129000.0 in 2025, then jumped by 86.82% to -$17000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$17000.0, -$129000.0, and -$106000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - | -63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -63,000.00 |
| Jun 30, 2026 | -63,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -129,000.00 |
| Dec 31, 2025 | -129,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Dec 31, 2024 | -159,000.00 |
| Dec 31, 2024 | -159,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Mar 31, 2024 | -35,000.00 |